Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Alzheimers Dement. 2023 Jan 25;19(7):3041–3054. doi: 10.1002/alz.12908

Table 2.

Associations of accelerometer measures of physical activity and sitting with incident mild cognitive impairment and probable dementia among older women in the Objective Physical Activity and Cardiovascular Health (OPACH) study 2012–2020.

Moderate-to-vigorous intensity physical activity (minutes/day)
Q1 (<23) Q2 (23–39) Q3 (39–61) Q4 (≥61) HR for 1-SD increment (31.2) P-trenda n
MCI events [rateb] 45 [36.8] 52 [42.0] 44 [31.0] 26 [18.3]
Model 1c 1 (ref) 1.14 (0.76–1.71) 0.91 (0.60–1.38) 0.61 (0.37–1.00) 0.81 (0.67–0.98) 0.030 1,284
Model 2c 1 (ref) 1.24 (0.79–1.95) 0.92 (0.57–1.50) 0.60 (0.34–1.07) 0.79 (0.63–0.98) 0.033 977
Model 2Ac 1 (ref) 1.26 (0.80–1.97) 0.91 (0.56–1.48) 0.64 (0.36–1.13) 0.80 (0.64–1.00) 0.047 1,042
Dementia events [rateb] 45 [33.8] 54 [39.8] 36 [23.5] 26 [17.7]
Model 1c 1 (ref) 1.17 (0.79–1.74) 0.77 (0.49–1.19) 0.66 (0.40–1.08) 0.81 (0.66–0.98) 0.031 1,331
Model 2c 1 (ref) 1.30 (0.82–2.05) 0.91 (0.54–1.51) 0.83 (0.47–1.45) 0.88 (0.70–1.10) 0.251 1,014
Model 2Ac 1 (ref) 1.21 (0.77–1.90) 0.84 (0.51–1.40) 0.79 (0.45–1.37) 0.86 (0.69–1.08) 0.189 1,082
MCI or dementia events [rateb] 74 [60.7] 88 [71.9] 61 [43.1] 44 [31.1]
Model 1c 1 (ref) 1.17 (0.86–1.60) 0.75 (0.53–1.06) 0.61 (0.41–0.89) 0.78 (0.67–0.90) 0.001 1,274
Model 2c 1 (ref) 1.29 (0.91–1.84) 0.81 (0.55–1.21) 0.66 (0.43–1.03) 0.79 (0.66–0.94) 0.007 967
Model 2Ac 1 (ref) 1.28 (0.91–1.81) 0.79 (0.53–1.17) 0.69 (0.45–1.06) 0.79 (0.67–0.94) 0.009 1,032
Light intensity physical activity (minutes/day)
Q1 (<226) Q2 (226–275) Q3 (275–323) Q4 (≥323) HR for 1-SD increment (70.7) P-trenda n
MCI events [rateb] 31 [24.7] 49 [35.8] 40 [29.5] 47 [35.5]
Model 1c 1 (ref) 1.54 (0.98–2.43) 1.26 (0.78–2.03) 1.63 (1.03–2.59) 1.14 (0.98–1.33) 0.081 1,284
Model 2c 1 (ref) 1.57 (0.93–2.63) 1.44 (0.84–2.48) 1.83 (1.05–3.21) 1.18 (0.98–1.43) 0.086 977
Model 2Ac 1 (ref) 1.56 (0.93–2.63) 1.41 (0.82–2.43) 1.89 (1.08–3.28) 1.19 (0.99–1.44) 0.064 1,042
Dementia events [rateb] 37 [27.5] 44 [29.7] 46 [31.8] 34 [24.1]
Model 1c 1 (ref) 1.16 (0.74–1.79) 1.25 (0.81–1.93) 0.99 (0.62–1.59) 0.97 (0.83–1.14) 0.734 1,331
Model 2c 1 (ref) 1.15 (0.70–1.89) 1.42 (0.86–2.33) 1.11 (0.63–1.95) 0.99 (0.81–1.21) 0.941 1,014
Model 2Ac 1 (ref) 1.10 (0.67–1.79) 1.28 (0.78–2.10) 1.08 (0.62–1.87) 0.97 (0.80–1.17) 0.730 1,082
MCI or dementia events [rateb] 55 [44.4] 77 [56.4] 67 [49.7] 68 [51.5]
Model 1c 1 (ref) 1.36 (0.96–1.93) 1.18 (0.82–1.69) 1.30 (0.91–1.86) 1.06 (0.94–1.20) 0.343 1,274
Model 2c 1 (ref) 1.47 (0.99–2.17) 1.33 (0.88–2.02) 1.41 (0.91–2.19) 1.07 (0.92–1.24) 0.398 967
Model 2Ac 1 (ref) 1.40 (0.95–2.06) 1.25 (0.83–1.88) 1.42 (0.93–2.18) 1.07 (0.92–1.23) 0.403 1,032
Steps (n/day)
Q1 (<1,867) Q2 (1,867–2,809) Q3 (2,809–4,050) Q4 (≥4,050) HR for 1-SD increment (1,865) P-trenda n
MCI events [rateb] 54 [50.4] 49 [36.0] 40 [28.1] 24 [16.6]
Model 1c 1 (ref) 0.72 (0.49–1.06) 0.60 (0.39–0.91) 0.39 (0.24–0.64) 0.74 (0.60–0.90) 0.003 1,284
Model 2c 1 (ref) 0.64 (0.40–1.01) 0.60 (0.37–1.00) 0.33 (0.18–0.61) 0.67 (0.51–0.87) 0.003 977
Model 2Ac 1 (ref) 0.62 (0.40–0.99) 0.60 (0.37–0.99) 0.36 (0.20–0.66) 0.69 (0.53–0.89) 0.006 1,042
Dementia events [rateb] 53 [43.6] 49 [33.4] 37 [24.5] 22 [14.8]
Model 1c 1 (ref) 0.81 (0.55–1.19) 0.63 (0.41–0.96) 0.42 (0.25–0.70) 0.70 (0.57–0.87) 0.001 1,331
Model 2c 1 (ref) 0.84 (0.53–1.31) 0.68 (0.41–1.13) 0.48 (0.26–0.88) 0.72 (0.56–0.92) 0.010 1,014
Model 2Ac 1 (ref) 0.83 (0.53–1.29) 0.65 (0.39–1.08) 0.48 (0.26–0.87) 0.71 (0.55–0.91) 0.008 1,082
MCI or dementia events [rateb] 84 [79.1] 81 [59.9] 65 [46.0] 37 [25.6]
Model 1c 1 (ref) 0.77 (0.57–1.05) 0.61 (0.44–0.84) 0.37 (0.25–0.55) 0.69 (0.59–0.81) <0.001 1,274
Model 2c 1 (ref) 0.75 (0.53–1.08) 0.66 (0.44–0.98) 0.35 (0.22–0.58) 0.65 (0.53–0.81) <0.001 967
Model 2Ac 1 (ref) 0.73 (0.51–1.03) 0.64 (0.43–0.94) 0.38 (0.23–0.61) 0.67 (0.54–0.82) <0.001 1,032
Sitting time (minutes/day)
Q1 (<569) Q2 (569–637) Q3 (637–704) Q4 (≥704) HR for 1-SD increment (97.2) P-trenda n
MCI events [rateb] 41 [31.3] 38 [27.9] 44 [33.9] 34 [29.3]
Model 1c 1 (ref) 0.83 (0.53–1.29) 0.94 (0.61–1.44) 0.81 (0.51–1.28) 0.92 (0.78–1.08) 0.286 1,234
Model 2c 1 (ref) 0.73 (0.44–1.20) 0.83 (0.51–1.37) 0.78 (0.45–1.34) 0.88 (0.72–1.07) 0.186 945
Model 2Ac 1 (ref) 0.75 (0.45–1.23) 0.86 (0.53–1.41) 0.78 (0.45–1.33) 0.89 (0.73–1.07) 0.220 1,005
Dementia events [rateb] 41 [29.6] 33 [22.7] 37 [26.0] 40 [32.8]
Model 1c 1 (ref) 0.74 (0.47–1.18) 0.81 (0.52–1.27) 0.94 (0.60–1.46) 0.97 (0.82–1.15) 0.734 1,277
Model 2c 1 (ref) 0.73 (0.44–1.22) 0.79 (0.48–1.31) 0.84 (0.49–1.44) 0.91 (0.75–1.10) 0.324 978
Model 2Ac 1 (ref) 0.70 (0.42–1.17) 0.79 (0.47–1.31) 0.90 (0.53–1.52) 0.94 (0.77–1.14) 0.521 1,041
MCI or dementia events [rateb] 69 [53.1] 58 [42.7] 64 [49.6] 61 [53.0]
Model 1c 1 (ref) 0.77 (0.54–1.09) 0.85 (0.60–1.20) 0.88 (0.62–1.25) 0.96 (0.85–1.09) 0.537 1,226
Model 2c 1 (ref) 0.73 (0.49–1.09) 0.79 (0.53–1.18) 0.82 (0.54–1.25) 0.91 (0.78–1.06) 0.246 937
Model 2Ac 1 (ref) 0.73 (0.49–1.08) 0.80 (0.54–1.19) 0.84 (0.56–1.26) 0.93 (0.80–1.08) 0.356 997
Mean sitting bout duration (minutes)
Q1 (<10.1) Q2 (10.1–12.7) Q3 (12.7–16.2) Q4 (≥16.2) HR for 1-SD increment (5.4) P-trenda n
MCI events [rateb] 36 [30.1] 37 [27.2] 43 [32.9] 41 [32.4]
Model 1c 1 (ref) 0.75 (0.47–1.20) 0.94 (0.60–1.47) 0.88 (0.55–1.39) 0.97 (0.82–1.14) 0.690 1,234
Model 2c 1 (ref) 0.88 (0.52–1.47) 0.99 (0.59–1.65) 0.88 (0.51–1.51) 0.92 (0.75–1.11) 0.378 945
Model 2Ac 1 (ref) 0.86 (0.52–1.42) 0.98 (0.59–1.61) 0.83 (0.49–1.42) 0.90 (0.74–1.10) 0.303 1,005
Dementia events [rateb] 33 [26.2] 33 [22.6] 41 [29.7] 44 [31.9]
Model 1c 1 (ref) 0.71 (0.44–1.16) 0.94 (0.59–1.50) 0.93 (0.59–1.48) 1.01 (0.86–1.19) 0.859 1,277
Model 2c 1 (ref) 0.67 (0.39–1.13) 0.88 (0.52–1.46) 0.90 (0.53–1.53) 1.00 (0.83–1.21) 0.979 978
Model 2Ac 1 (ref) 0.72 (0.42–1.21) 0.92 (0.55–1.54) 1.00 (0.60–1.69) 1.03 (0.86–1.24) 0.739 1,041
MCI or dementia events [rateb] 54 [45.4] 57 [42.0] 71 [55.0] 70 [55.5]
Model 1c 1 (ref) 0.77 (0.53–1.13) 1.04 (0.73–1.49) 1.00 (0.69–1.43) 1.02 (0.90–1.15) 0.788 1,226
Model 2c 1 (ref) 0.83 (0.55–1.26) 1.02 (0.68–1.53) 0.96 (0.63–1.47) 0.97 (0.84–1.13) 0.704 937
Model 2Ac 1 (ref) 0.83 (0.55–1.24) 1.03 (0.69–1.53) 0.98 (0.65–1.48) 0.98 (0.85–1.13) 0.777 997
Light intensity steps (n/day)
Q1 (<1,236) Q2 (1,236–1,693) Q3 (1,693–2,191) Q4 (≥2,191) HR for 1-SD increment (728) P-trenda n
MCI events [rateb] 37 [32.2] 55 [39.7] 33 [23.5] 42 [30.7]
Model 1c 1 (ref) 1.23 (0.81–1.87) 0.74 (0.46–1.2) 1.12 (0.71–1.75) 1.04 (0.88–1.23) 0.650 1,284
Model 2c 1 (ref) 1.12 (0.70–1.81) 0.78 (0.45–1.34) 1.18 (0.69–2.04) 1.08 (0.88–1.33) 0.435 977
Model 2Ac 1 (ref) 1.07 (0.66–1.72) 0.79 (0.46–1.35) 1.15 (0.67–1.97) 1.08 (0.88–1.32) 0.460 1,042
Dementia events [rateb] 45 [35.8] 50 [33.4] 34 [22.9] 32 [22.1]
Model 1c 1 (ref) 0.96 (0.64–1.43) 0.70 (0.44–1.09) 0.73 (0.46–1.15) 0.87 (0.73–1.04) 0.118 1,331
Model 2c 1 (ref) 0.81 (0.52–1.26) 0.59 (0.35–0.99) 0.70 (0.41–1.19) 0.86 (0.69–1.06) 0.156 1,014
Model 2Ac 1 (ref) 0.86 (0.55–1.34) 0.59 (0.35–0.99) 0.69 (0.40–1.18) 0.85 (0.69–1.05) 0.129 1,082
MCI or dementia events [rateb] 62 [54.2] 89 [65.0] 56 [40.1] 60 [44.1]
Model 1c 1 (ref) 1.22 (0.88–1.69) 0.76 (0.53–1.10) 0.92 (0.64–1.32) 0.93 (0.81–1.06) 0.280 1,274
Model 2c 1 (ref) 1.10 (0.76–1.59) 0.75 (0.49–1.14) 0.95 (0.62–1.46) 0.94 (0.80–1.11) 0.472 967
Model 2Ac 1 (ref) 1.09 (0.76–1.56) 0.75 (0.50–1.13) 0.94 (0.61–1.43) 0.94 (0.80–1.10) 0.433 1,032
Moderate-to-vigorous intensity steps (n/day)
Q1 (<1,222) Q2 (1,222–1,670) Q3 (1,670–2,185) Q4 (≥2,185) HR for 1-SD increment (1,502) P-trenda n
MCI events [rateb] 52 [44.0] 57 [44.3] 33 [24.0] 25 [17.1]
Model 1c 1 (ref) 1.00 (0.68–1.46) 0.61 (0.39–0.96) 0.47 (0.29–0.76) 0.75 (0.60–0.94) 0.011 1,284
Model 2c 1 (ref) 1.04 (0.68–1.60) 0.61 (0.36–1.02) 0.48 (0.27–0.87) 0.73 (0.56–0.96) 0.024 977
Model 2Ac 1 (ref) 1.01 (0.66–1.55) 0.61 (0.37–1.02) 0.49 (0.28–0.89) 0.74 (0.56–0.97) 0.027 1,042
Dementia events [rateb] 43 [32.5] 56 [40.1] 36 [24.6] 26 [17.3]
Model 1c 1 (ref) 1.25 (0.84–1.87) 0.88 (0.56–1.38) 0.66 (0.40–1.09) 0.87 (0.71–1.07) 0.181 1,331
Model 2c 1 (ref) 1.43 (0.90–2.27) 1.18 (0.70–2.00) 0.90 (0.50–1.64) 1.00 (0.80–1.24) 0.968 1,014
Model 2Ac 1 (ref) 1.34 (0.85–2.11) 1.09 (0.65–1.83) 0.89 (0.49–1.59) 0.98 (0.79–1.23) 0.878 1,082
MCI or dementia events [rateb] 76 [64.8] 93 [73.1] 56 [40.9] 42 [28.9]
Model 1c 1 (ref) 1.11 (0.82–1.51) 0.69 (0.48–0.98) 0.52 (0.35–0.76) 0.76 (0.64–0.90) 0.002 1,274
Model 2c 1 (ref) 1.25 (0.88–1.77) 0.82 (0.55–1.24) 0.61 (0.38–0.98) 0.80 (0.65–0.97) 0.026 967
Model 2Ac 1 (ref) 1.20 (0.85–1.69) 0.80 (0.54–1.19) 0.63 (0.40–0.99) 0.80 (0.65–0.97) 0.027 1,032

Abbreviations: MCI=mild cognitive impairment

a

P-values from Cox models with accelerometer measures in continuous form.

b

Crude incidence rate per 1000 person-years

c

Data are hazard ratio (95% confidence interval)

Model 1 adjusted for age, race and ethnicity, and education; Model 2 = Model 1 + smoking status + alcohol use + diabetes + hypertension + RAND-36 physical functioning score + APOE ε4 + BMI

*

p<0.05 (p=0.047)

Model 2A results were estimated with missing covariate data for women with APOE ε4 data imputed using multiple imputation by chained equations (MICE) from the R mice package.